Top compounds associated with response to TRPV4


Feature Type Standardized
Nominal ANOVA
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.005
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.006
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.1 0.006
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.13 0.007
mRNA XMD8-92 GDSC1000 pan-cancer AAC 0.13 0.008
mRNA AZ628 GDSC1000 pan-cancer AAC 0.15 0.008
mRNA ML311 CTRPv2 pan-cancer AAC -0.088 0.008
mRNA SB-225002 CTRPv2 pan-cancer AAC -0.083 0.009
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.15 0.009
mRNA RAF265 CTRPv2 pan-cancer AAC 0.11 0.009
Download CSV